Hybrid nanofibers based on poly-caprolactone/gelatin/hydroxyapatite nanoparticles-loaded Doxycycline: Effective anti-tumoral and antibacterial activity-Reference-Cited by-同舟云学术

Hybrid nanofibers based on poly-caprolactone/gelatin/hydroxyapatite nanoparticles-loaded Doxycycline: Effective anti-tumoral and antibacterial activity

Published:2018-02 Issue: Volume:83 Page:25-34
ISSN:0928-4931
Container-title:Materials Science and Engineering: C
language:en
Short-container-title:Materials Science and Engineering: C

Author:

Ramírez-Agudelo Ricardo,Scheuermann Karina,Gala-García Alfonso,Monteiro Ana Paula F.,Pinzón-García Ana Delia,Cortés Maria E.,Sinisterra Rubén D.

Funder

INCT-Nanobiofar

CNPq

CAPES

FAPEMIG

Publisher

Elsevier BV

Subject

Biomaterials,Bioengineering,Mechanics of Materials

Reference69 articles.

1. Targeting metastasis;Steeg;Nat. Rev. Cancer,2016

2. Safety and efficacy of doxycycline in the treatment of rosacea;Valentín;Clin. Cosmet. Investig. Dermatol.,2009

3. Doxycycline and other tetracyclines in the treatment of bone metastasis;Saikali;Anti-Cancer Drugs,2003

4. Structural and thermodynamic characterization of doxycycline/β-cyclodextrin supramolecular complex and its bacterial membrane interactions;Suárez;Colloids Surf. B: Biointerfaces,2014

5. Minocycline: far beyond an antibiotic;Garrido-Mesa;Br. J. Pharmacol.,2013

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZnO Katkılı PCL+PVC-N3 Polimerlerinin Yapısal ve Optiksel Özellikleri;International Journal of Pure and Applied Sciences;2024-06-30

2. Development of porous hydroxyapatite/PVA/gelatin/alginate hybrid flexible scaffolds with improved mechanical properties for bone tissue engineering;Materials Chemistry and Physics;2024-06

3. Investigate release of DOX drug in electrospun DOX@SiO2/PVA nanofiber;2024-04-02

4. Trends in the Incorporation of Antiseptics into Natural Polymer-Based Nanofibrous Mats;Polymers;2024-02-29

5. Natural Polymers as a Carrier for the Effective Delivery of Antineoplastic Drugs;Current Drug Delivery;2024-02